☆ 4.7 Editorial Material

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Get Full Text
Add to Collection

Journal

CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 69, Issue 6, Pages 1141-1151

Publisher

SPRINGER
DOI: 10.1007/s00262-020-02502-1

Keywords

Immunotherapy; Cancer vaccines; Checkpoint blockade agents; Adoptive immunotherapy; Targeted therapies; NIBIT

Categories

Oncology Immunology

Funding

  1. Roche
  2. Bristol-Meyers Squibb
  3. Novartis
  4. Pierre Fabre
  5. Amgen
  6. MSD Oncology
  7. Biotechne
  8. Incyte
  9. Euroclone
  10. Labospace
  11. Italian Association for Cancer Research (AIRC)
  12. Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri (OMCeO, Milano)
  13. Regione Lombardia
  14. Societa Italiana di Cancerologia
  15. Ospedale San Raffaele ed Universita Vita-Salute San Raffaele

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.